• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道间质瘤有哪些新进展?

What is New in Gastrointestinal Stromal Tumor?

机构信息

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

出版信息

Adv Anat Pathol. 2017 Sep;24(5):259-267. doi: 10.1097/PAP.0000000000000158.

DOI:10.1097/PAP.0000000000000158
PMID:28632504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5608028/
Abstract

The classification "gastrointestinal stromal tumor" (GIST) became commonplace in the 1990s and since that time various advances have characterized the GIST lineage of origin, tyrosine kinase mutations, and mechanisms of response and resistance to targeted therapies. In addition to tyrosine kinase mutations and their constitutive activation of downstream signaling pathways, GISTs acquire a sequence of chromosomal aberrations. These include deletions of chromosomes 14q, 22q, 1p, and 15q, which harbor putative tumor suppressor genes required for stepwise progression from microscopic, preclinical forms of GIST (microGIST) to clinically relevant tumors with malignant potential. Recent advances extend our understanding of GIST biology beyond that of the oncogenic KIT/PDGFRA tyrosine kinases and beyond mechanisms of KIT/PDGFRA-inhibitor treatment response and resistance. These advances have characterized ETV1 as an essential interstitial cell of Cajal-GIST transcription factor in oncogenic KIT signaling pathways, and have characterized the biologically distinct subgroup of succinate dehydrogenase deficient GIST, which are particularly common in young adults. Also, recent discoveries of MAX and dystrophin genomic inactivation have expanded our understanding of GIST development and progression, showing that MAX inactivation is an early event fostering cell cycle activity, whereas dystrophin inactivation promotes invasion and metastasis.

摘要

“胃肠道间质瘤”(GIST)的分类在 20 世纪 90 年代变得很普遍,自那时以来,GIST 的起源、酪氨酸激酶突变以及对靶向治疗的反应和耐药机制的各种进展已经得到了描述。除了酪氨酸激酶突变及其下游信号通路的组成性激活外,GIST 还获得了一系列染色体异常。这些异常包括染色体 14q、22q、1p 和 15q 的缺失,这些染色体携带着逐步进展所需的潜在肿瘤抑制基因,从微观、临床前形式的 GIST(microGIST)到具有恶性潜能的临床相关肿瘤。最近的进展扩展了我们对 GIST 生物学的理解,超越了致癌 KIT/PDGFRA 酪氨酸激酶及其 KIT/PDGFRA 抑制剂治疗反应和耐药机制的理解。这些进展将 ETV1 确定为致癌 KIT 信号通路中 Cajal-GIST 转录因子的必需间质细胞,并确定了生物上不同的琥珀酸脱氢酶缺乏型 GIST 亚组,该亚组在年轻人中特别常见。此外,最近发现 MAX 和肌营养不良蛋白基因组失活扩展了我们对 GIST 发生和进展的理解,表明 MAX 失活是促进细胞周期活性的早期事件,而肌营养不良蛋白失活则促进侵袭和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/62b78084d8a4/nihms873247f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/156550854662/nihms873247f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/2d4de2bf6e20/nihms873247f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/096cd981c364/nihms873247f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/3ea314cdc7b7/nihms873247f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/62b78084d8a4/nihms873247f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/156550854662/nihms873247f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/2d4de2bf6e20/nihms873247f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/096cd981c364/nihms873247f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/3ea314cdc7b7/nihms873247f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419f/5608028/62b78084d8a4/nihms873247f5.jpg

相似文献

1
What is New in Gastrointestinal Stromal Tumor?胃肠道间质瘤有哪些新进展?
Adv Anat Pathol. 2017 Sep;24(5):259-267. doi: 10.1097/PAP.0000000000000158.
2
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.血小板衍生生长因子受体-α通过稳定ETV1来调节KIT基因发生突变的胃肠道间质瘤细胞的增殖。
Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.
3
Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.小儿KIT野生型和血小板衍生生长因子受体α野生型胃肠道间质瘤具有KIT激活,但在遗传进展机制方面与成人胃肠道间质瘤不同。
Cancer Res. 2007 Oct 1;67(19):9084-8. doi: 10.1158/0008-5472.CAN-07-1938.
4
Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour.胃肠道间质瘤(GIST)中出现横纹肌样形态与 PDGFRA 突变相关,但并不意味着侵袭性行为。
Histopathology. 2014 Feb;64(3):421-30. doi: 10.1111/his.12265. Epub 2013 Nov 22.
5
MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.丝裂原活化蛋白激酶激活蛋白激酶 2 过表达影响胃肠道间质瘤的预后,并与 1 号染色体上的拷贝数变异以及 p38MAP 激酶和 ETV1 的表达相关。
Clin Cancer Res. 2012 Apr 1;18(7):1879-87. doi: 10.1158/1078-0432.CCR-11-2364. Epub 2012 Feb 20.
6
Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.原发性 PDGFRA 突变胃肠道间质瘤的染色体异常。
Hum Pathol. 2014 Jan;45(1):85-97. doi: 10.1016/j.humpath.2013.05.027. Epub 2013 Oct 21.
7
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.ETV1信使核糖核酸在胃肠道间质瘤中特异性表达。
Virchows Arch. 2015 Oct;467(4):393-403. doi: 10.1007/s00428-015-1813-9. Epub 2015 Aug 5.
8
MicroRNA involvement in gastrointestinal stromal tumor tumorigenesis.微小 RNA 参与胃肠道间质瘤的发生。
Curr Pharm Des. 2013;19(7):1227-35. doi: 10.2174/138161213804805748.
9
KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.胃肠道间质瘤中KIT癌蛋白相互作用:治疗相关性
Oncogene. 2007 Sep 27;26(44):6386-95. doi: 10.1038/sj.onc.1210464. Epub 2007 Apr 23.
10
Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.胃肠道间质瘤 22q 杂合性缺失和缺乏 INI1 基因突变。
Pathobiology. 2011;78(3):132-9. doi: 10.1159/000323564. Epub 2011 May 26.

引用本文的文献

1
Anti-LGI1-antibody autoimmune encephalitis as a neurological paraneoplastic syndrome associated with gastrointestinal stromal tumour: a case report.抗LGI1抗体自身免疫性脑炎作为一种与胃肠道间质瘤相关的神经副肿瘤综合征:一例报告
Postep Psychiatr Neurol. 2025 Jun;34(2):108-115. doi: 10.5114/ppn.2025.150016. Epub 2025 Jun 23.
2
Gastrointestinal stromal tumors: Clinicopathological features and outcome-Real-world experience.胃肠道间质瘤:临床病理特征与预后——真实世界经验
Indian J Gastroenterol. 2025 Jun 28. doi: 10.1007/s12664-025-01800-9.
3
Long-term outcomes of endoscopic treatment versus surgical resection for 0-2 cm gastrointestinal stromal tumor: A SEER database study.

本文引用的文献

1
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.辅助伊马替尼治疗胃肠间质瘤患者中 KIT 和 PDGFRA 突变对生存的影响:一项随机临床试验的探索性分析。
JAMA Oncol. 2017 May 1;3(5):602-609. doi: 10.1001/jamaoncol.2016.5751.
2
Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to Splitting.确定辅助治疗在分子定义的胃肠道间质瘤亚组中的影响:从合并到细分
JAMA Oncol. 2017 May 1;3(5):597-599. doi: 10.1001/jamaoncol.2016.5740.
3
内镜治疗与手术切除治疗0-2厘米胃肠道间质瘤的长期结局:一项监测、流行病学和最终结果(SEER)数据库研究
Surg Endosc. 2025 May 14. doi: 10.1007/s00464-025-11720-6.
4
Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors.胃肠道间质瘤的全基因组DNA甲基化和拷贝数改变
Genes Chromosomes Cancer. 2025 Mar;64(3):e70046. doi: 10.1002/gcc.70046.
5
Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report.十二指肠胃肠道间质瘤的阴茎转移:一例罕见病例报告。
Urol Case Rep. 2025 Feb 7;59:102978. doi: 10.1016/j.eucr.2025.102978. eCollection 2025 Mar.
6
Soft tissue sarcomas at the single-cell and spatial resolution: new markers and targets.单细胞和空间分辨率下的软组织肉瘤:新的标志物和靶点
Cancer Gene Ther. 2025 Jan;32(1):11-21. doi: 10.1038/s41417-024-00856-7. Epub 2024 Nov 24.
7
Managing locally advanced GIST complicated by perforation: A case report and comprehensive review.局部晚期胃肠间质瘤合并穿孔的治疗:一例病例报告及综合综述
Radiol Case Rep. 2024 Aug 12;19(11):4824-4831. doi: 10.1016/j.radcr.2024.07.105. eCollection 2024 Nov.
8
Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research.胃肠道间质瘤中的基因突变:治疗进展与机制研究
Glob Med Genet. 2024 Aug 22;11(4):251-262. doi: 10.1055/s-0044-1789204. eCollection 2024 Dec.
9
Diagnostic Complexity and Long-Term Management of Gastrointestinal Stromal Tumor Mimicking Ovarian Origin: A Case Report.疑似卵巢起源的胃肠道间质瘤的诊断复杂性及长期管理:一例报告
Cureus. 2024 Jul 14;16(7):e64523. doi: 10.7759/cureus.64523. eCollection 2024 Jul.
10
Gastrointestinal Stromal Tumors: A Retrospective Study at a Tertiary Care Center in Saudi Arabia in the Last Decade.胃肠道间质瘤:沙特阿拉伯一家三级医疗中心过去十年的回顾性研究
Cureus. 2024 Jul 15;16(7):e64560. doi: 10.7759/cureus.64560. eCollection 2024 Jul.
GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
表现为腹膜后肿瘤的胃肠道间质瘤:112例临床病理、免疫组织化学及分子遗传学研究
Am J Surg Pathol. 2017 May;41(5):577-585. doi: 10.1097/PAS.0000000000000807.
4
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.MAX 失活是 GIST 发展过程中的早期事件,它调节 p16 和细胞增殖。
Nat Commun. 2017 Mar 8;8:14674. doi: 10.1038/ncomms14674.
5
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.晚期胃肠间质瘤伊马替尼长期疗效与下一代测序结果的相关性:SWOG 多中心临床试验 S0033 分析
JAMA Oncol. 2017 Jul 1;3(7):944-952. doi: 10.1001/jamaoncol.2016.6728.
6
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.一大组胃肠道间质瘤(GISTs)的临床病理和分子特征及文献综述:KIT/PDGFRA野生型GISTs中的BRAF突变是罕见事件。
Hum Pathol. 2017 Apr;62:206-214. doi: 10.1016/j.humpath.2017.01.005. Epub 2017 Feb 1.
7
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.“野生型”胃肠道间质瘤中的FGFR1和NTRK3可靶向改变
J Transl Med. 2016 Dec 14;14(1):339. doi: 10.1186/s12967-016-1075-6.
8
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.四阴性 GIST 是未识别的神经纤维瘤病 1 型综合征的标志物。
Clin Cancer Res. 2017 Jan 1;23(1):273-282. doi: 10.1158/1078-0432.CCR-16-0152. Epub 2016 Jul 7.
9
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.瑞戈非尼用于标准酪氨酸激酶抑制剂治疗失败后的转移性和/或不可切除胃肠道间质瘤患者的多中心II期试验的长期随访结果
Ann Oncol. 2016 Sep;27(9):1794-9. doi: 10.1093/annonc/mdw228. Epub 2016 Jul 1.
10
Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.传统风险分层无法预测琥珀酸脱氢酶缺乏型胃肠道间质瘤的进展:一项76例病例的临床病理研究
Am J Surg Pathol. 2016 Dec;40(12):1616-1621. doi: 10.1097/PAS.0000000000000685.